2 Nov 2023 , 10:28 AM
Result date: November 6, 2023
Recommendation: Reduce
Target price: Rs. 3,055
Analysts at IIFL Capital Services expect Divi’s Laboratories to post 3% growth in revenue as compared to the year-ago quarter. They are baking in Nil contribution from Molnu in the September 2023 quarter versus USD 37 million in the year-ago quarter. Ex-Molnu CS revenue could grow 45% as compared to the year-ago quarter, owing to depressed base of last year.
Profit After Tax or PAT is likely to decline 15% over the year-ago quarter.
Rs. Million |
September 2023 estimates |
YoY change |
QoQ change |
Revenue |
19,128 |
3.1% |
7.6% |
EBITDA |
6,025 |
(3.0)% |
19.6% |
EBITDA margin (%) |
31.5% |
(199) bps |
315 bps |
Profit After Tax |
4,216 |
(14.6)% |
18.4% |
Source: IIFL Research
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.